MEDIFAST INC Annual Cost of Revenue in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Medifast Inc quarterly/annual Cost of Revenue history and growth rate from 2010 to 2024.
  • Medifast Inc Cost of Revenue for the quarter ending December 31, 2024 was $30.8M, a 38% decline year-over-year.
  • Medifast Inc Cost of Revenue for the twelve months ending December 31, 2024 was $158M, a 46.7% decline year-over-year.
  • Medifast Inc annual Cost of Revenue for 2024 was $158M, a 46.7% decline from 2023.
  • Medifast Inc annual Cost of Revenue for 2023 was $296M, a 35.4% decline from 2022.
  • Medifast Inc annual Cost of Revenue for 2022 was $458M, a 15% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $158M -$138M -46.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-18
2023 $296M -$162M -35.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-18
2022 $458M +$59.7M +15% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-18
2021 $398M +$161M +68.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $237M +$60.2M +34.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $177M +$55.7M +46% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 $121M +$47.4M +64.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $73.8M +$4.88M +7.09% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $68.9M -$2.59M -3.62% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $71.5M -$4.62M -6.07% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 $76.1M -$7.41M -8.88% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $83.5M +$826K +1% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $82.7M +$8.97M +12.2% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 $73.7M +$8.61M +13.2% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 $65.1M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.